Blaine Davis

Blaine Davis is a declared insider at 2 companies (finance chief); the most frequent names are Cartesian Therapeutics, Inc. and Protara Therapeutics, Inc. We count 9 filings; the first trade dates from 22 September 2020 and the latest from 6 January 2026.

Both buying and selling appear: 1 purchase worth €21k, against 3 sales worth €192k. The net balance comes to €171k on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 5 share grants. Since January 2026: no purchases and 1 sale on the market.

On 8 January 2026 came the latest disclosure, an open-market sale for €62k in Cartesian Therapeutics, Inc. The last purchase on record was published on 23 September 2020, which is 2,221 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.